A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders

The specific NKCC1 cotransporter antagonist, bumetanide, attenuates the severity of Autism Spectrum Disorders (ASD), and many neurodevelopmental or neurodegenerative disorders in animal models and clinical trials. However, the pervasive expression of NKCC1 in many cell types throughout the body is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Delpire, Eric, Ben-Ari, Yehezkel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367773/
https://www.ncbi.nlm.nih.gov/pubmed/35954263
http://dx.doi.org/10.3390/cells11152419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367773/
https://www.ncbi.nlm.nih.gov/pubmed/35954263
http://dx.doi.org/10.3390/cells11152419

Ejemplares similares